R.PR
REGISTERED-PRINCIPAL REGISTER
09/14/2021
Back to search
Official data from USPTO
BIOKORF
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
75
Latest update
09/14/2021
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
06/06/2017
Registration date
09/14/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/14/2021
Last transaction
09/14/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/15/2020
First use in commerce
10/12/2020
Drawing code
3
Owner type
16
Owner location
West Lafayette, IN
Examiner
DIBLE, IAN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the gray stylized wording "BIOKORF" below a design resembling a mountain range comprising two chevrons displayed in various shades of green with gray shadows.
Holders and representatives
Holders
Biokorf LLC
Representatives
Biokorf LLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of mental abnormalities; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hormone replacement; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparationsantidepressants; Pharmaceuticalsantihelmintics; Pharmaceuticalspsychotropics; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; Unit dose capsules sold empty for pharmaceutical use
Class 42
Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals
Class 44
Pharmaceutical advice; Pharmaceutical compounding services; Dispensing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
75 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/10/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/16/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/14/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/18/2021
GNFR
FINAL REFUSAL E-MAILED
01/18/2021
CNFR
SU - FINAL REFUSAL - WRITTEN
01/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2020
ALIE
ASSIGNED TO LIE
12/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/21/2020
GNRT
NON-FINAL ACTION E-MAILED
10/21/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/21/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/15/2020
IUAF
USE AMENDMENT FILED
10/13/2020
EISU
TEAS STATEMENT OF USE RECEIVED
10/13/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/29/2020
EX5G
SOU EXTENSION 5 GRANTED
08/28/2020
NREV
NOTICE OF REVIVAL - E-MAILED
08/21/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
08/20/2020
PETG
PETITION TO REVIVE-GRANTED
08/20/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
08/20/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08/03/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
08/03/2020
DOCK
ASSIGNED TO EXAMINER
07/23/2020
EXT5
SOU EXTENSION 5 FILED
07/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/10/2020
EX4G
SOU EXTENSION 4 GRANTED
03/09/2020
NREV
NOTICE OF REVIVAL - E-MAILED
03/07/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
03/06/2020
PETG
PETITION TO REVIVE-GRANTED
03/06/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
03/06/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02/03/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
02/03/2020
EXT4
SOU EXTENSION 4 FILED
01/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/13/2019
EX3G
SOU EXTENSION 3 GRANTED
11/12/2019
NREV
NOTICE OF REVIVAL - E-MAILED
10/07/2019
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
10/07/2019
PETG
PETITION TO REVIVE-GRANTED
10/07/2019
PROA
TEAS PETITION TO REVIVE RECEIVED
10/07/2019
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08/05/2019
ABN6
ABANDONMENT - NO USE STATEMENT FILED
08/05/2019
EXT3
SOU EXTENSION 3 FILED
07/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/09/2019
EX2G
SOU EXTENSION 2 GRANTED
04/08/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/05/2019
NREV
NOTICE OF REVIVAL - E-MAILED
03/02/2019
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
03/02/2019
PETG
PETITION TO REVIVE-GRANTED
03/02/2019
PROA
TEAS PETITION TO REVIVE RECEIVED
03/02/2019
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02/04/2019
ABN6
ABANDONMENT - NO USE STATEMENT FILED
02/04/2019
EXT2
SOU EXTENSION 2 FILED
01/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/30/2018
EX1G
SOU EXTENSION 1 GRANTED
06/28/2018
EXT1
SOU EXTENSION 1 FILED
06/28/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/28/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/29/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2017
ALIE
ASSIGNED TO LIE
09/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2017
DOCK
ASSIGNED TO EXAMINER
09/06/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/13/2017
NWAP
NEW APPLICATION ENTERED
06/09/2017
Continuous trademark protection
Get notified about every new filing that threatens BIOKORF or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.